Rush University Medical Center is among the backers of Transcarent’s series C round, which pushed the company’s overall financing to $298m.
Transcarent, a US-based operator of a personalised healthcare platform for employers, secured $200m in a series C round on Tuesday from a consortium featuring Rush University Medical Center, the teaching hospital of Rush University.
Kinnevik and Human Capital co-led the round, with participation from health systems Northwell Health and Intermountain Healthcare, pharmaceutical firm Merck & Co’s Global Healthcare Innovation Fund, Ally Bridge, General Catalyst, 7wireVentures, Alta Partners, Jove Equity Partners, Threshold Ventures and GreatPoint Ventures.
Transcarent runs a healthcare platform…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
